polyneuropathies with paralysis and muscle atrophy. Interdisciplinary cooperation Professor Skripuletz as a neurologist and Professor Bavendiek as a cardiologist are the main coordinators in the Amyloidosis Centre [...] further information , please contact Professor Dr. Udo Bavendiek, Clinic for Cardiology and Angiology, bavendiek.udo@mh-hannover.de , telephone (0511) 532-2229, and Professor Dr. Thomas Skripuletz, Clinic for [...] protein fragments are misfolded, they clump together and are deposited in the tissue," explains Professor Dr. Thomas Skripuletz, senior physician at the Department of Neurology with Clinical Neurophysiology

intestine, skin, liver and lungs. Professor Dr. Sarina Ravens and Dr. Alina Fichtner from the Institute of Immunology at the Hannover Medical School (MHH) and Professor Dr. Immo Prinz and Dr. Likai Tan [...] adulthood" can be found here . For more information , please contact Professor Dr Sarina Ravens, Ravens.Sarina@mh-hannover.de and Professor Dr Immo Prinz, Prinz.Immo@mh-hannover.de . [...] innovative high-throughput sequencing method based on the individual analysis of each cell," says Professor Ravens. Using this technology, the team studied gamma-delta T cells in cord blood samples as well

at Hannover Medical School (MHH). The study leaders, Clinic Director Professor Dr. Johann Bauersachs and Senior Physician Professor Dr. Udo Bavendiek, are now pleased about a milestone: with Torsten S [...] SERVICE: For further information , please contact Professor Dr. Udo Bavendiek, Bavendiek.Udo@mh-hannover.de , telephone (0511) 532-2229 and Professor Dr. Johann Bauersachs, Bauersachs.Johann@mh-hannover [...] and the associated amount of data is already a great treasure for initial analyses," explains Professor Bavendiek. With the data, we will probably not only be able to answer our initial question, but

Experimental Haematology (Professor Dr Dr Axel Schambach, Philippe Vollmer Barbosa), the MHH Clinic for Haematology, Haemostaseology, Oncology and Stem Cell Transplantation (Professor Dr Dr Adrian Schwarzer) [...] 2.5 million euros for the further development of new antiviral agents. The research team led by Professor Dr Dr Axel Schambach, Head of the Institute of Experimental Haematology at Hannover Medical School [...] paralyse different sections of the parainfluenza virus genome that the virus needs to replicate," says Professor Schambach. Effectiveness of RNAi candidates successfully tested in lung tissue RNAi technology uses

tion offensive in medicine," says Professor Kahl. The project is a cooperation between MHH, Leibniz Universität Hannover (Professor Dr Michael H. Breitner, Professor Dr Annika Herr, PD Dr Jan Zeidler) [...] available in Germany, they are only used by less than one percent of those affected. A study led by Professor Dr. Kai G. Kahl, Managing Senior Physician at the Department of Psychiatry, Social Psychiatry and [...] for those affected and for society due to illness-related unemployment or early retirement," says Professor Kahl. Only about a quarter of those with the disease take part in therapy at all. Among other things

Furthermore, Professor Figueiredo is interested in allogeneic cell therapies for regenerative purposes, including innovative Blood Pharming strategies and Bioreactor technologies. Professor Figueiredo is [...] 9711 +49 511 532 2079 figueiredo.constanca @ mh-hannover.de ABOUT Constanca Figueiredo is Full Professor of Allogeneic Cell Therapy at the Institute of Transfusion Medicine and Transplant Engineering at [...] 2006, she continued to develop the research area of Transplant Engineering at the same institute. Professor Figueiredo is highly interested in cell and gene therapeutic approaches in the field of transfusion

to later stages of life,” explains Professor Dr. Siegfried Geyer, Head of Medical Sociology at Hannover Medical School (MHH). From this positive perspective, Professor Geyer and his working group investigated [...] the health status of different age groups in the population developed. Compression and expansion Professor Geyer and his team have been working on the topic of “compression and expansion of morbidity” since [...] at the period from 2005 to 2019 and compared cohorts of the same age at different times,” says Professor Geyer. The surprising result: the health status of the elderly, which used to improve over the years

Clinic for Radiotherapy and Special Oncology, headed by Professor Dr. Hans Christiansen, and the Clinic for Cardiology and Angiology, headed by Professor Dr. Johann Bauersachs, work closely together on this [...] significantly reduced. That is a huge gain for those affected," explains Professor Duncker. SERVICE: For more information , contact Professor Dr Roland Merten, Clinic for Radiotherapy and Special Oncology, merten [...] life-threatening cardiac arrhythmias despite the generally very good treatment options," explains Professor Dr. David Duncker, head of the Hannover Heart Rhythm Centre (HHC) at the Clinic for Cardiology and

deficiency,” explains Professor Dr. Johann Bauersachs, Director of the Department of Cardiology and Angiology. Professor Bauersachs is leading the pilot study together with Professor Dr. Tibor Kempf, senior [...] patients with heart failure. “The current treatment guidelines only recommend infusions,” says Professor Kempf. In the pilot study ORION-HF, cardiologists are now testing an iron preparation that has already [...] therapy with the tablets leads to an increase in haemoglobin and iron levels in the blood,” explains Professor Kempf. For the patients, this would mean that they would be better supplied with oxygen and suffer

years of work, this commission has made up-to-date recommendations on how COPD can be reduced. Professor Dr. Tobias Welte, Director of the Department of Pneumology at the Hannover Medical School (MHH) [...] diseases such as asthma, there has been no breakthrough in the treatment of COPD for decades," says Professor Welte. "We are, so to speak, at the therapeutic standard of the 1960s." According to the lung expert [...] insufficient because it does not reliably detect early signs of changes in the airways," emphasises Professor Welte. In general, the diagnosis is made much too late. "The individual courses of the disease vary